Evidence of Herd Immunity and Sustained Impact of Rotavirus Vaccination on the Reduction of Rotavirus-Related Medical Encounters Among Infants from 2006 through 2011 in the United States-Reference-Cited by-同舟云学术

Evidence of Herd Immunity and Sustained Impact of Rotavirus Vaccination on the Reduction of Rotavirus-Related Medical Encounters Among Infants from 2006 through 2011 in the United States

Published:2015-06 Issue:6 Volume:34 Page:615-620
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Mast T. Christopher,Wang Florence T.,Su Sue,Seeger John D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference28 articles.

1. WHO-coordinated Global Rotavirus Surveillance Network. 2008 Estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.;Tate;Lancet Infect Dis,2012

2. Burden of childhood rotavirus disease on health systems in the United States: results from active surveillance before rotavirus vaccine introduction.;Mast;Pediatr Infect Dis J,2010

3. Cost-effectiveness analysis of a rotavirus immunization program for the United States.;Tucker;JAMA,1998

4. Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.;Ruiz-Palacios;N Engl J Med,2006

5. Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.;Vesikari;N Engl J Med,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health impact of rotavirus vaccination in China;Human Vaccines & Immunotherapeutics;2024-09-13

2. Molecular evolutionary analysis of novel NSP4 mono-reassortant G1P[8]-E2 rotavirus strains that caused a discontinuous epidemic in Japan in 2015 and 2018;Frontiers in Microbiology;2024-07-10

3. A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions;Microorganisms;2023-12-31

4. Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques;Vaccine;2023-08

5. Assessment of the Impact of the Rotavirus Vaccine Against Severe Rotaviral Diarrhea in Uzbekistan;Journal of Epidemiology and Global Health;2023-06-10